Sebaceous neoplasms with mismatch repair protein expressions and the frequency of co-existing visceral tumors

Journal of the American Academy of Dermatology

Volumn 67, Issue 6, 2012, Pages

  Lee, Bonnie A ^a   Yu, Limin ^c   Ma, Linglei ^c   Lind, Anne C ^a   Lu, Dongsi ^a,b  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b ST LUKE S HOSPITAL   (United States)

^c UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

mismatch repair; Muir Torre syndrome; sebaceous neoplasms; visceral malignancy

Indexed keywords

MISMATCH REPAIR PROTEIN;

ADULT; AGED; ARTICLE; COLON ADENOMA; CONTROLLED STUDY; DISEASE SURVEILLANCE; FAMILY HISTORY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; NEOPLASM; POLYP; PREVALENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SEBACEOUS GLAND TUMOR; UROGENITAL TRACT TUMOR;

EID: 84869103035     PISSN: 01909622     EISSN: 10976787     Source Type: Journal    
DOI: 10.1016/j.jaad.2012.03.020     Document Type: Article

References (23)

1. E.G. Muir, A.J. Bell, and K.A. Barlow Multiple primary carcinomata of the colon, duodenum, and larynx associated with kerato-acanthomata of the face Br J Surg 54 1967 191 195
2. D. Torre Multiple sebaceous tumors Arch Dermatol 98 1968 549 551
3. R.A. Schwartz, and D.P. Torre The Muir-Torre syndrome: a 25-year retrospect J Am Acad Dermatol 33 1995 90 104
4. H.T. Lynch, P.M. Lynch, J. Pester, and R.M. Fusaro The cancer family syndrome: rare cutaneous phenotypic linkage of Torre's syndrome Arch Intern Med 141 1981 607 611
5. H.T. Lynch, and J.F. Lynch 25 Years of HNPCC Anticancer Res 14 1994 1617 1624
6. R. Honchel, K.C. Halling, D.J. Schaid, M. Pittelkow, and S.N. Thibodeau Microsatellite instability in Muir-Torre syndrome Cancer Res 54 1994 1159 1163
7. G. Ponti, and M. Ponz de Leon Muir-Torre syndrome Lancet Oncol 6 2005 980 987
8. A.M. Cesinaro, A. Ubiali, P. Sighinolfi, G.P. Trentini, F. Gentili, and F. Facchetti Mismatch repair proteins expression and microsatellite instability in skin lesions with sebaceous differentiation: a study in different clinical subgroups with and without extracutaneous cancer Am J Dermatopathol 29 2007 351 358
9. R. Kruse, A. Rutten, H.R. Hosseiny-Malayeri, M. Bisceglia, W. Friedl, and P. Propping "Second hit" in sebaceous tumors from Muir-Torre patients with germline mutations in MSH2: allele loss is not the preferred mode of inactivation J Invest Dermatol 116 2001 463 465
10. M. Mathiak, A. Rutten, E. Mangold, H.P. Fischer, T. Ruzicka, and W. Friedl Loss of DNA mismatch repair proteins in skin tumors from patients with Muir-Torre syndrome and MSH2 or MLH1 germline mutations: establishment of immunohistochemical analysis as a screening test Am J Surg Pathol 26 2002 338 343
11. M.C. Southey, M.A. Young, J. Whitty, S. Mifsud, M. Keilar, and L. Mead Molecular pathologic analysis enhances the diagnosis and management of Muir-Torre syndrome and gives insight into its underlying molecular pathogenesis Am J Surg Pathol 25 2001 936 941
12. V. Chhibber, K. Dresser, and M. Mahalingam MSH-6: extending the reliability of immunohistochemistry as a screening tool in Muir-Torre syndrome Mod Pathol 21 2008 159 164
13. E. Mangold, N. Rahner, N. Friedrichs, R. Buettner, C. Pagenstecher, and S. Aretz MSH6 mutation in Muir-Torre syndrome: could this be a rare finding? Br J Dermatol 156 2007 158 162
14. L. Orta, D.S. Klimstra, J. Qin, P. Mecca, L.H. Tang, and K.J. Busam Towards identification of hereditary DNA mismatch repair deficiency: sebaceous neoplasm warrants routine immunohistochemical screening regardless of patient's age or other clinical characteristics Am J Surg Pathol 33 2009 934 944
15. M.C. Finan, and S.M. Connolly Sebaceous gland tumors and systemic disease: a clinicopathologic analysis Medicine (Baltimore) 63 1984 232 242
16. P.R. Cohen, S.R. Kohn, and R. Kurzrock Association of sebaceous gland tumors and internal malignancy: the Muir-Torre syndrome Am J Med 90 1991 606 613
17. J. Rothenberg, W.C. Lambert, J.T. Vail Jr., A.S. Nemlick, and R.A. Schwartz The Muir-Torre (Torre's) syndrome: the significance of a solitary sebaceous tumor J Am Acad Dermatol 23 1990 638 640
18. A. Jemal, R. Siegel, E. Ward, T. Murray, J. Xu, and M.J. Thun Cancer statistics, 2007 CA Cancer J Clin 57 2007 43 66
19. W. Edelmann, K. Yang, A. Umar, J. Heyer, K. Lau, and K. Fan Mutation in the mismatch repair gene Msh6 causes cancer susceptibility Cell 91 1997 467 477
20. A. Mojtahed, I. Schrijver, J.M. Ford, T.A. Longacre, and R.K. Pai A two-antibody mismatch repair protein immunohistochemistry screening approach for colorectal carcinomas, skin sebaceous tumors, and gynecologic tract carcinomas Mod Pathol 24 2011 1004 1014
21. M.M. Entius, J.J. Keller, P. Drillenburg, K.C. Kuypers, F.M. Giardiello, and G.J. Offerhaus Microsatellite instability and expression of hMLH-1 and hMSH-2 in sebaceous gland carcinomas as markers for Muir-Torre syndrome Clin Cancer Res 6 2000 1784 1789
22. R.S. Singh, W. Grayson, M. Redston, A.H. Diwan, C.L. Warneke, and P.H. McKee Site and tumor type predicts DNA mismatch repair status in cutaneous sebaceous neoplasia Am J Surg Pathol 32 2008 936 942
23. W.J. Catalona, D.S. Smith, T.L. Ratliff, K.M. Dodds, D.E. Coplen, and J.J. Yuan Measurement of prostate-specific antigen in serum as a screening test for prostate cancer N Engl J Med 324 1991 1156 1161